Noom GLP-1 Cost: What Noom Med Actually Charges Per Month

How much does Noom GLP-1 (Noom Med) cost per month?

Noom Med sells three real GLP-1 medication tracks, and the price depends entirely on which one you land on. The entry-level Microdose GLP-1Rx program starts at $79 for the first four-week supply, then runs $199 a month. The standard GLP-1Rx program — full-dose compounded semaglutide — starts at $129, then runs $249 a month. GLP-1Rx Plus, Noom's compounded tirzepatide track, starts at $149, then runs $299 a month. There's also a non-GLP-1 Weight Loss Pill plan built around metformin, which starts at $69 and runs $99 a month — Noom's own site notes that metformin is not FDA-approved for weight loss, so it's a different category of product from the other three.

• Microdose GLP-1Rx (compounded semaglutide, lower dose): $79 to start, $199/mo ongoing
• GLP-1Rx (compounded semaglutide, standard dose): $129 to start, $249/mo ongoing
• GLP-1Rx Plus (compounded tirzepatide): $149 to start, $299/mo ongoing
• Weight Loss Pill (metformin, not a GLP-1): $69 to start, $99/mo ongoing

The detail easy to miss on the pricing page: every one of those "per month" figures is actually billed every 12 weeks as a single lump charge — $597 for Microdose, $747 for standard GLP-1Rx, $897 for GLP-1Rx Plus. The monthly figure is a divided-by-three convenience number, not what actually hits your card. If you're used to a true monthly subscription like Fridays or Henry Meds, budget for a quarterly charge roughly three times the size instead.

Is there a membership fee on top of that price, or is it all-in?

For the three GLP-1 tiers above, no — there's no separate membership layer stacked on top of the medication price. What you see is the full charge: clinician oversight, the medication, and app access are bundled into that one quarterly bill. That's a genuine structural difference from Mochi Health, which bills a $79 membership and the medication as two independent subscriptions.

There's one plan where this doesn't hold: the branded-medication telehealth option. That track runs $149 to start and $99 a month afterward for the clinical relationship and prescription coordination, but the brand-name medication itself — Wegovy, Ozempic, or Zepbound — is billed separately, either through insurance or out of pocket. If you're chasing brand-name GLP-1 access specifically, that's the plan structured differently from the rest of the Noom Med lineup.

What happened with the Noom cancellation lawsuit, and does it affect billing today?

In Mahood v. Noom, Inc., Noom settled a class action covering roughly $56M in cash payouts plus $6M in subscription credits — commonly reported together as a $62M settlement — after plaintiffs alleged the company made it difficult to cancel auto-renewing subscriptions and enrolled users in annual plans without sufficiently clear consent. The class period ran from May 2016 through October 2020, which predates Noom Med's GLP-1 program entirely; the suit was about the classic Noom Healthy Weight app subscription. The settlement received final court approval in 2023, and Noom agreed to changes including clearer pre-purchase disclosures, automatic autorenewal shutoff for inactive accounts, and an easier-to-find cancellation flow.

Whether that history still matters for Noom Med billing specifically is a fair question. It's worth knowing that recent BBB complaints include at least one 2026 case describing a customer's card being charged for three additional months after cancelling a GLP-1 subscription — not proof of a systemic issue, but a documented instance in the same vein as the earlier lawsuit. The practical takeaway: confirm the cancellation steps before you enroll, and check your statement for a month or two after you cancel.

What's actually included in the monthly price?

Across the three GLP-1 tracks, the price covers more than just the drug.

• Initial clinician evaluation and prescription decision
• The compounded GLP-1 medication itself, shipped to you
• Ongoing dose-adjustment visits and 24/7 messaging access to your care team
• Full Noom app access — the psychology-based curriculum, food and weight tracking, and 1:1 coaching content
• GLP-1Rx (standard) adds weekly dose check-ins through what Noom calls its adaptive titration protocol

What's not included — costs to budget for separately

A few things sit outside that quarterly charge. Insurance doesn't apply to any of the compounded-medication tiers — that's standard across this entire category, not a Noom-specific gap, and it only changes on the branded-medication telehealth track where a prescription can potentially route through your own coverage. Lab work isn't bundled into the GLP-1Rx plans as standard; if your clinician wants baseline bloodwork, you're arranging and paying for that separately unless your primary care provider already orders it. FSA and HSA cards are generally accepted at checkout across the medication-inclusive plans, though whether your specific plan reimburses it depends on your administrator. And Noom Med isn't available in every state, so it's worth confirming your state is covered before you complete an intake.

How much does the Noom microdose semaglutide plan cost, and is it worth it as a cheaper entry point?

At $199 a month, Microdose GLP-1Rx is Noom's cheapest medicated tier — $50 less than the standard semaglutide program. The premise is a sub-therapeutic starting dose, marketed as a gentler on-ramp for people worried about side effects or who want to titrate more slowly. As a lower-cost way to start GLP-1 treatment with clinical oversight, that's a reasonable option worth considering on price alone.

One thing worth knowing before you lean on the marketing pitch specifically: in May 2026, the advertising self-regulation body NAD recommended Noom modify or discontinue its "A Smaller Dose. A Smarter Start" claim for the Microdose program, following a challenge from Eli Lilly. NAD's finding wasn't that microdosing is unsafe or ineffective — it was that Noom hadn't substantiated the specific claim that the lower dose itself delivers a measurable health advantage over starting at a standard dose. That's a marketing-substantiation finding, not a safety finding, but it's a reasonable reason to treat "smarter start" as a slogan rather than a clinical fact when you're deciding whether the cheaper tier is right for you.

How much does Noom cost per year?

Multiplying the quarterly bill by four gives a realistic annual total for each track.

• Microdose GLP-1Rx: $199/mo x 12 ≈ $2,388/yr
• GLP-1Rx (standard semaglutide): $249/mo x 12 ≈ $2,988/yr
• GLP-1Rx Plus (tirzepatide): $299/mo x 12 ≈ $3,588/yr
• Weight Loss Pill (metformin): $99/mo x 12 ≈ $1,188/yr

A full year of Noom Med runs from roughly $2,400 on the cheapest medicated tier to roughly $3,600 for tirzepatide, before any lab costs you arrange on your own.

How does Noom's cost compare to Fridays, Mochi Health, and Henry Meds?

Fridays — cheaper on an annual commitment, comparable month-to-month

Fridays' compounded semaglutide runs about $249 a month month-to-month, or about $150 a month if you prepay a full year — both bundle a dietitian and group coaching the way Noom bundles its app curriculum. Its tirzepatide runs about $359 month-to-month or $240 annually. Against Noom's $249/mo standard semaglutide and $299/mo tirzepatide, Fridays' month-to-month rates land close to Noom's, while its annual-prepay rate undercuts Noom on both molecules — at the cost of a large non-refundable upfront commitment.

Mochi Health — a two-part bill that can land cheaper or pricier depending on the math

Mochi charges a $79 membership plus $99 for semaglutide or $199 for tirzepatide, landing at $178 a month all-in for semaglutide and $278 a month for tirzepatide — both cheaper than Noom's equivalent tiers. The tradeoff is billing complexity: membership and medication are two separate subscriptions that renew and must be cancelled independently, versus Noom's single quarterly charge. Full breakdown in the Mochi Health cost guide.

Henry Meds — no membership fee, and consistently cheaper than Noom

Henry Meds prices semaglutide at $249 a month oral or $297 injectable, and tirzepatide at $349 oral or $449 injectable, all-in with no separate membership charge — and billed monthly, not in a quarterly lump. On oral semaglutide the two are essentially tied; everywhere else, Henry Meds' oral formats undercut Noom, though its injectable tirzepatide runs higher than Noom's GLP-1Rx Plus. See the Henry Meds cost guide for the full tier breakdown.

The throughline: Noom is rarely the cheapest option for the medication alone. What it's selling instead is its behavioral coaching app bundled in at every tier — a real differentiator if you'd actually use the psychology-based curriculum, and a premium you're paying for even if you wouldn't.

Is there a Noom coupon or discount that lowers the price?

Honestly: not one specific to Noom Med that holds up. Search for "Noom coupon" and you'll find aggregator sites advertising 50% to 80% off, but those codes overwhelmingly apply to the classic Noom Weight behavioral app — the ~$70/mo non-medical program — not the GLP-1 medication tiers. The reduced "to get started" price on each Noom Med plan (as low as $69-$149 for the first four weeks) is already the built-in discount; it's not a stackable coupon on top. The most reliable way to lower your real cost is paying with an FSA or HSA card, which discounts the price by your marginal tax rate rather than a percentage off the sticker.

Is Noom Med worth the price?

If you'd genuinely use Noom's coaching app — the daily lessons, tracking, and psychology-based curriculum — the case for paying more than Henry Meds or Mochi Health gets stronger, because you're buying a second product bundled into the medication price. If you mainly want the prescription and clinical oversight with minimal extras, Noom Med is consistently at or above what the cheapest compounded-only competitors charge for the same molecule, and the quarterly billing cadence is worth planning around rather than being surprised by.

The lawsuit history and the recent NAD finding on the microdose marketing claim aren't reasons to rule Noom Med out — they're reasons to read the cancellation terms closely and treat the "smarter start" pitch as marketing rather than a proven clinical edge.